RL3-65821-52979
4 vaccinations
1 coded response
28 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 282 / NC
- Registered
- 2021-02-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-26
Registered in v-safe
-
2021-02-26
Dose 1 — Pfizer-BioNTech
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-04
- 2021-03-05
- 2021-03-14
-
2021-03-19
Dose 2 — Pfizer-BioNTech
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-28
- 2021-04-02
- 2021-04-09
- 2021-04-18
- 2021-04-23
- 2021-04-30
- 2021-06-18
- 2021-09-18
-
2021-10-07
Dose 3 — Pfizer-BioNTech
- 2022-03-19
-
2022-09-27
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-07
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid in MayMedDRA releases: 2024-11 · check-in free text available
- 2022-10-08
- 2022-10-18
- 2022-11-08
- 2022-12-27
- 2023-03-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-26 | Pfizer-BioNTech | |
| 2 | 2021-03-19 | Pfizer-BioNTech | |
| 3 | 2021-10-07 | Pfizer-BioNTech | No |
| 4 | 2022-09-27 | Pfizer-BioNTech | Flu |
Free text
Release 12 — 12 months, dose 3
Symptoms: Covid in May
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release